Category: misconduct investigations

Uni dings schizophrenia studies for problems with informed consent, other flaws

Psychiatry journals have retracted two papers evaluating a schizophrenia drug after a university in Japan flagged issues, such as a lack of written informed consent.

The papers—published in Human Psychopharmacology: Clinical & Experimental in 2012 and Psychiatry and Clinical Neurosciences in 2014—examined the safety and effectiveness of an antipsychotic drug in patients with schizophrenia.

According to the retraction notice in Psychiatry and Clinical Neurosciences, the ethics committee at St. Marianna University School of Medicine in Kawasaki found that “the trial included subjects who did not satisfy inclusion criteria.” For instance, not all patients provided written informed consent. But the university found no evidence for data falsification or fabrication.

A spokesperson for Human Psychopharmacology told us: Continue reading Uni dings schizophrenia studies for problems with informed consent, other flaws

Work by group at Australian university faces scrutiny

A journal is investigating research by a group in Australia, after receiving “serious allegations” regarding a 2017 paper about treating eye burns.

The journal, Frontiers in Pharmacology, has issued an expression of concern (EOC) for the 2017 paper while it investigates. The notice does not specify the nature of the allegations.  Meanwhile, several other papers by the three researchers, based at Deakin University in Geelong, Australia, have also come under scrutiny. Late last month, Frontiers in Pharmacology retracted a 2015 paper by Kislay Roy, Rupinder Kanwar, and Jagat R Kanwar, citing image duplication. A 2015 paper in Biomaterials received a correction in May 2017, again flagging image duplication.

Roy, the first author on the papers, is a postdoctoral research fellow; Rupinder Kanwar, a middle author, is a senior lecturer; and Jagat R Kanwar, the corresponding author on all three, is head of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research.

Gearóid Ó Faoleán, the ethics and integrity manager at Frontiers in Pharmacology, explained that the investigation into the flagged article is ongoing and the EOC “must serve as the extent of our public statement for the present.”

A spokesperson for Deakin University declined to comment on the allegations: Continue reading Work by group at Australian university faces scrutiny

Weizmann bans grad students from researcher’s lab over “serious misconduct”

Rony Seger

The Weizmann Institute in Israel has barred a biologist from mentoring graduate students, after an investigation uncovered ” a case of serious misconduct that included manipulation of data.”

In a letter posted on PubPeer, President Daniel Zajfman describes some of the disciplinary measures taken against an unnamed scientist, including also retracting or correcting all affected papers. Michal Neeman, vice president of The Weizmann Institute of Science, confirmed to us that the letter describes Rony Seger, a molecular biologist who has already retracted 11 papers.

Neeman told us the investigation was unable to determine who was responsible for the manipulations, but as the head of his lab, Seger was ultimately accountable:

Continue reading Weizmann bans grad students from researcher’s lab over “serious misconduct”

What a report into scientific misconduct reveals: The case of Frank Sauer

Oct. 3, 2011, was the beginning of the end for Frank Sauer’s tenure at the University of California, Riverside. On that day, an anonymous emailer contacted Sauer’s institution with accusations that the biochemist had cooked his research in at least eight papers over a 16-year period.

Sauer was found to have doctored images in studies using government money — nearly $3 million of it. He went on to lose his position at UC Riverside, several papers to retraction, and, in May, a subsequent legal battle over the severity of the federal sanctions. Along the way, he concocted a fantastic tale of sabotage against German scientists (like himself), replete with poison-pen letters and fabricated credentials. 

Retraction Watch has obtained a copy of UC Riverside’s report on the Sauer case through a public records request. The report, which is undated but which describes committee meetings and interviews from October 2011 to October 2012, lists 33 allegations of scientific misconduct against Sauer, 20 of which the committee determined to involve deception. Of the remaining 13, the committee either could not find proof of guilt or determined that the data were legitimate.

Continue reading What a report into scientific misconduct reveals: The case of Frank Sauer

Science journal flags cancer paper under investigation for image manipulation

Science Signaling has issued an expression of concern for a 2016 paper, citing an institutional investigation into image manipulation.

According to a spokesperson for the journal, the corresponding author, Tanya Kalin, became concerned that two images in the paper had been manipulated. Kalin then notified the research integrity officer at Cincinnati Children’s Hospital Medical Center, where she is based.

On May 9 2017, Kalin alerted the journal to the investigation. A week later, the hospital’s research integrity officer followed up with the journal, flagging the figures under question.  The journal then prepared an expression of concern (EOC) to alert readers to the issues and the institution’s investigation.  

Here’s the EOC notice for “The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5:” Continue reading Science journal flags cancer paper under investigation for image manipulation

NIH neuroscientist up to 19 retractions

Stanley Rapoport.
Source: NIH

The string of apparent bad luck continues for Stanley Rapoport.

Rapoport, a neuroscientist based at the U.S. National Institute on Aging, has lost three more papers in three journals due to the misconduct of his co-authors. By our count, these retractions bring his tally to 19 — and tie him for 21st place on our leaderboard.

The journals—Schizophrenia Research, Journal of Affective Disorders, and Biological Psychiatry— retracted the papers because the National Institutes of Health had found that one of Rapoport’s co-authors, Jagadeesh Rao, had “engaged in research misconduct by falsifying data.” Rao was corresponding author on all three papers.

According to a spokesperson for Elsevier, which publishes the journals, the Schizophrenia Research paper was retracted in July, the JAD paper in late May and the Biological Psychiatry paper in late April. The spokesperson told us that the publisher first received an email from the NIH about the misconduct findings on September 20, 2016, and that: Continue reading NIH neuroscientist up to 19 retractions

Leibniz Prize belatedly awarded to scientist cleared of misconduct

Just before the March ceremony to bestow the coveted Leibniz Prize, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) received some disturbing allegations. An anonymous tipster accused one of the 10 scientists slotted to receive the award, materials scientist Britta Nestler, of misconduct. So the DFG held the ceremony on March 15, but suspended Nestler’s award.

Four months later, Nestler now has her Leibniz, along with the €2.5 million in prize money. This week, the DFG — which awards the Leibniz — announced that it had given Nestler her prize on July 4, during its annual meeting, after determining the accusations were without merit.

Secretary General of the DFG and Chair of the Committee of Inquiry on Allegations of Scientific Misconduct Dorothee Dzwonnek said in a statement:

Continue reading Leibniz Prize belatedly awarded to scientist cleared of misconduct

Failed whistleblower suit is a reminder that public universities are hard to sue

The University of Louisville’s Kornhauser Library via Wikimedia

Suing the government is difficult. And because public universities often function as an arm of state governments, that makes them hard to sue, too, a fact reiterated in a whistleblower case decided earlier this year.

In January, Judge David Hale of the Western District of Kentucky dismissed a lawsuit filed by former employees of the University of Louisville alleging that the institution fraudulently secured millions in federal grants due to a biosafety program that had fallen out of compliance with federal regulations. The biosafety officers also alleged that they were wrongly terminated for pointing out the compliance issues to Louisville, the National Institutes of Health, and even the Federal Bureau of Investigation. But the judge’s order came before those issues would even be considered.

According to the suit, filed in 2015, plaintiffs Karen Brinkley and Carol Whetstone alleged that the university, seven principal investigators, and an administrator had worked to wrongly obtain as much as $165 million from the National Institutes of Health. Around 2008, according to the plaintiffs, the defendants began allowing persistent biosafety issues — improper training and biological material disposal methods, protocols with expired institutional biosafety committee approvals, performance of research tasks in labs with insufficient biosafety ratings — to taint their applications for multiple federal grants (the complaint didn’t specify how many). Brinkley and Whetstone filed suit under the False Claims Act (FCA), which allows individuals to recover money on behalf of the U.S. government; allegedly, the grants were improperly obtained because the defendants had certified that they were in compliance with NIH’s biosafety requirements, even though they knew that they were not. Continue reading Failed whistleblower suit is a reminder that public universities are hard to sue

The retraction countdown: How quickly do journals pull papers?

After Tina Wenz was found guilty of scientific misconduct, how long did it take for journals to retract the problematic papers?  The answer: Between three and nine months.

In September 2016, the University of Cologne found that Wenz had committed scientific misconduct in six papers and requested they all be retracted. From that point on, the retraction clock was ticking.

We’ve explored how long it takes a journal to act over the years, and we’ve found that the time between identifying a problem to retracting the paper can vary — and sometimes last years.

In Wenz’s case, one of the papers—published in Cell Metabolism in 2009—had already been retracted in 2015. Three of the remaining five were retracted in December 2016—a 2008 paper in Cell Metabolism, a 2009 paper in Proceedings of the National Academy of Sciences (PNAS), and a 2009 paper in the Journal of Applied Physiology.

In January 2017, the journal IUBMB Life pulled a 2014 paper flagged in the investigation. And just over nine months after Wenz was found guilty of misconduct, the last paper—published in 2013 in Mitochondrion—has been retracted.

The most recent notice states that the University of Cologne requested the retractions, after determining that the data had been “inappropriately manipulated.”

Here’s the retraction notice in Mitochondrion:

Continue reading The retraction countdown: How quickly do journals pull papers?

Soon-to-be-ex-rector of top Belgium university blames coverage of misconduct case for ouster

May was quite a month for Rik Torfs, the rector of a prominent university in Belgium. On May 9, Torfs lost his re-election campaign for rector of KU Leuven by a slim margin—out of more than 2100 votes, he lost by a mere 48. And just 20 days later, on May 29, Torfs wrote his final column for the Flemish daily newspaper De Standaard  — whom he believes was at least partly to blame for his election loss.

Specifically, it was the paper’s reporting on the university hospital’s (UZ Leuven) investigation into pediatric oncologist Stefaan Van Gool, which came just months before the election, that Torfs said he believes may have led to his ouster: Continue reading Soon-to-be-ex-rector of top Belgium university blames coverage of misconduct case for ouster